cucurbitacins has been researched along with Adenocarcinoma in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Ferreira, MU; Molnar, J; Mulhovo, S; Ramalhete, C; Silva, CD; Spengler, G | 1 |
| Achmad, TH; Al-Najjar, BO; Choi, SB; Diantini, A; Manurung, JV; Muchtaridi, M; Subarnas, A; Wahab, HA; Wardhani, SR; Yusuf, M | 1 |
2 other study(ies) available for cucurbitacins and Adenocarcinoma
| Article | Year |
|---|---|
Triterpenes from Momordica balsamina (African pumpkin): ABCB1 inhibition and synergistic interaction with doxorubicin in resistant cancer cells.
Topics: Adenocarcinoma; Animals; ATP Binding Cassette Transporter, Subfamily B; Cell Line, Tumor; Colonic Neoplasms; Cucurbita; Cucurbitacins; Doxorubicin; Drug Resistance, Neoplasm; Humans; Lymphoma; Methanol; Mice; Momordica; Plant Extracts; Rhodamines; Triterpenes; Verapamil | 2022 |
Potential activity of fevicordin-A from Phaleria macrocarpa (Scheff) Boerl. seeds as estrogen receptor antagonist based on cytotoxicity and molecular modelling studies.
Topics: Adenocarcinoma; Antineoplastic Agents, Phytogenic; Breast; Breast Neoplasms; Cell Death; Cell Line, Tumor; Cucurbitacins; Estrogen Receptor alpha; Estrogen Receptor Antagonists; Female; Humans; Molecular Docking Simulation; Molecular Dynamics Simulation; Seeds; Thermodynamics; Thymelaeaceae | 2014 |